Article
N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines.
Cancer letters - 28 Jun 2002
Zou Changping, Guan Yongli, Zou Changchun, Wang Jian, Wang Li-E, Liebert Monica, Grossman H Barton, Wei Qingyi
Abstract excerpt
We previously demonstrated that N-(4-hydroxyphenyl)retinamide (4-HPR) and gamma-irradiation, when used in combination, had a synergistic effect in inducing apoptosis in bladder cancer cells, suggesting that 4-HPR may increase radiosensitivity in bladder cancer cells. To unravel molecular correlates in this radiosensitizing effect of 4-HPR, we examined the baseline and 4-HPR-induced expression of GADD45 to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
